MOTIV Study- Effect of Antidepressive Treatment by Escitalopram in Patients Undergoing Coronary Artery Bypass Grafting
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of an antidepressive medication
(Escitalopram), started preoperatively and given during 6 months, on 6-month and 1 year
post-operative morbidity and mortality after coronary artery bypass grafting